Estabrook Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.33K Buy
+116
New +$8.94K ﹤0.01% 285
2025
Q1
Sell
-18,771
Closed -$843K 334
2024
Q4
$843K Sell
18,771
-20,800
-53% -$1.17M 0.13% 83
2024
Q3
$2.49M Sell
39,571
-2,800
-7% -$163K 0.37% 59
2024
Q2
$2.5M Sell
42,371
-1,619
-4% -$101K 0.39% 58
2024
Q1
$3.51M Sell
43,990
-75
-0.2% -$5.73K 0.54% 46
2023
Q4
$3.48M Sell
44,065
-1,850
-4% -$132K 0.57% 46
2023
Q3
$3.21M Sell
45,915
-510
-1% -$36.1K 0.56% 45
2023
Q2
$3.21M Sell
46,425
-700
-1% -$49.8K 0.53% 50
2023
Q1
$3.5M Hold
47,125
0.61% 47
2022
Q4
$4.39M Buy
47,125
+3
+0% +$289 0.76% 38
2022
Q3
$4.49M Sell
47,122
-80
-0.2% -$7.92K 0.84% 36
2022
Q2
$4.37M Sell
47,202
-747
-2% -$72.9K 0.75% 38
2022
Q1
$4.85M Buy
47,949
+7
+0% +$735 0.71% 40
2021
Q4
$4.95M Buy
47,942
+2,608
+6% +$241K 0.7% 39
2021
Q3
$3.85M Sell
45,334
-809
-2% -$67.8K 0.61% 50
2021
Q2
$3.85M Sell
46,143
-2,992
-6% -$245K 0.59% 51
2021
Q1
$3.7M Buy
49,135
+427
+0.9% +$31.1K 0.57% 52
2020
Q4
$3.33M Sell
48,708
-396
-0.8% -$25.8K 0.55% 52
2020
Q3
$2.87M Buy
49,104
+45,454
+1,245% +$2.83M 0.53% 52
2020
Q2
$237K Buy
3,650
+175
+5% +$11K 0.05% 121
2020
Q1
$206K Buy
3,475
+175
+5% +$11.7K 0.04% 118
2019
Q4
$245K Buy
3,300
+2,879
+684% +$202K 0.04% 132
2019
Q3
$26.6K Buy
421
+121
+40% +$7.17K ﹤0.01% 243
2019
Q2
$16.3K Hold
300
﹤0.01% 268
2019
Q1
$16.2K Buy
300
+288
+2,400% +$17.8K ﹤0.01% 275
2018
Q4
$786 Hold
12
﹤0.01% 320
2018
Q3
$945 Sell
12
-250
-95% -$17.9K ﹤0.01% 342
2018
Q2
$16.9K Sell
262
-180
-41% -$11.9K ﹤0.01% 297
2018
Q1
$27.5K Sell
442
-775
-64% -$55.6K ﹤0.01% 265
2017
Q4
$88.2K Sell
1,217
-3,990
-77% -$290K 0.01% 189
2017
Q3
$423K Sell
5,207
-1,730
-25% -$137K 0.07% 108
2017
Q2
$558K Sell
6,937
-820
-11% -$64.7K 0.09% 99
2017
Q1
$609K Sell
7,757
-1,740
-18% -$139K 0.1% 93
2016
Q4
$749K Sell
9,497
-47,932
-83% -$3.88M 0.12% 86
2016
Q3
$5.11M Buy
57,429
+7,050
+14% +$665K 0.75% 42
2016
Q2
$4.82M Sell
50,379
-3,233
-6% -$322K 0.72% 41
2016
Q1
$5.56M Buy
53,612
+2,570
+5% +$250K 0.82% 42
2015
Q4
$4.99M Buy
51,042
+6,123
+14% +$600K 0.72% 42
2015
Q3
$4.33M Buy
44,919
+27,855
+163% +$2.93M 0.63% 45
2015
Q2
$1.79M Buy
17,064
+8,354
+96% +$854K 0.22% 67
2015
Q1
$899K Buy
+8,710
New +$881K 0.11% 92

Other funds holding CVS

Estabrook Capital Management's CVS Position: Q1 2026 in Review

Estabrook Capital Management opened a new position in CVS Health (CVS) in Q1 2026: 116 shares worth $8.33K. The stake represents ﹤0.01% of the portfolio and ranks #285 among its holdings. This is a return to the name: Estabrook Capital Management previously reported a position in CVS as recently as Q4 2024.

Estabrook Capital Management first reported a position in CVS in Q1 2015 and has held it in 41 quarters since. The position peaked at $5.56M in Q1 2016. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Estabrook Capital Management held 116 shares of CVS Health worth $8.33K as of Q1 2026.
  • CVS Health was a new Estabrook Capital Management position in Q1 2026.
  • CVS Health made up ﹤0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #285 holding.
  • Estabrook Capital Management first reported a position in CVS Health in Q1 2015 and has held it in 41 quarters since.
  • Estabrook Capital Management's CVS Health position peaked at $5.56M in Q1 2016.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.